Cargando…
Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
OBJECTIVE: Gonadotropin-releasing hormone agonists (GnRHa) are the treatment of choice for central precocious puberty (CPP) and have been widely used for several decades. We determined the effect of GnRHa treatment on the auxological outcomes of girls with idiopathic CPP. METHODS: This study include...
Autores principales: | Lee, Hae Sang, Yoon, Jong Seo, Park, Kyu Jung, Hwang, Jin Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104939/ https://www.ncbi.nlm.nih.gov/pubmed/30133462 http://dx.doi.org/10.1371/journal.pone.0201906 |
Ejemplares similares
-
Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015) -
Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2023) -
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023) -
Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
por: Kwon, Ahreum
Publicado: (2023) -
Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2021)